Philipp Burkard
Impact in
-
- Venous Thromboembolism Diagnosis and Management
- Hematology top 10%
- Platelet Disorders and Treatments
Papers in
-
- Platelet Disorders and Treatments 6
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 3
- Galectins and Cancer Biology 2
- Co-authors
- Bernhard Nieswandt (8 shared papers)Timo Vögtle (3 shared papers)David Stegner (5 shared papers)Attila Braun (1 shared paper)Diego Mezzano (1 shared paper)Paquita Nurden (2 shared papers)Katharina A. Remer (1 shared paper)Jesús Gil‐Pulido (1 shared paper)
- Journals
- Blood (2 papers)Blood Advances (2 papers)Nature Communications (1 paper)Journal of Leukocyte Biology (1 paper)International Journal of Molecular Sciences (1 paper)
- Partner nations
- GermanyUnited StatesSweden
In The Last Decade
Philipp Burkard
12 papers receiving 325 citations
Peers
Comparison fields: 5 of 65
- Internal Medicine 21
- Hematology 71
- Immunology 82
- Oncology 86
- Cancer Research 29
Countries citing papers authored by Philipp Burkard
This map shows the geographic impact of Philipp Burkard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Burkard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Burkard more than expected).
Fields of papers citing papers by Philipp Burkard
This network shows the impact of papers produced by Philipp Burkard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Burkard. The network helps show where Philipp Burkard may publish in the future.
Co-authors
The 25 scholars most cited alongside Philipp Burkard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 133 | |
| 2 | 2023 | 59 | |
| 3 | 1994 | 35 | |
| 4 | 2016 | 33 | |
| 5 | 2020 | 27 | |
| 6 | 2022 | 17 | |
| 7 | 2022 | 14 | |
| 8 | 2023 | 3 | |
| 9 | 2021 | 3 | |
| 10 | 2025 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2025 | 1 | |
| 13 | 2025 | 0 | |
| 14 | 2026 | 0 |
About Philipp Burkard
Philipp Burkard is a scholar working on Hematology, Immunology, Epidemiology, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 14 papers that have together received 327 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (6 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Galectins and Cancer Biology (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Social Media in Health Education (1 paper), Inflammatory Biomarkers in Disease Prognosis (1 paper) and Respiratory Support and Mechanisms (1 paper). The work is most often cited by research in Internal Medicine (21 citations), Hematology (71 citations), Immunology (82 citations), Oncology (86 citations) and Cancer Research (29 citations). Philipp Burkard has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Bernhard Nieswandt, Timo Vögtle, David Stegner, Attila Braun, Diego Mezzano, Paquita Nurden, Katharina A. Remer, Jesús Gil‐Pulido, Scott I. Abrams and Elmina Mammadova‐Bach. Their work appears in journals such as Blood, Blood Advances, Nature Communications, Journal of Leukocyte Biology and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.